<VariationArchive RecordType="classified" VariationID="16488" VariationName="NM_000146.4(FTL):c.469_484dup (p.Leu162fs)" VariationType="Duplication" Accession="VCV000016488" Version="3" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-12-11" DateCreated="2017-07-22" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31527" VariationID="16488">
      <GeneList>
        <Gene Symbol="FTL" FullName="ferritin light chain" GeneID="2512" HGNC_ID="HGNC:3999" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="48965309" stop="48966879" display_start="48965309" display_stop="48966879" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="49468565" stop="49470135" display_start="49468565" display_stop="49470135" Strand="+" />
          </Location>
          <OMIM>134790</OMIM>
          <Haploinsufficiency last_evaluated="2013-08-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FTL">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-08-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FTL">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000146.4(FTL):c.469_484dup (p.Leu162fs)</Name>
      <CanonicalSPDI>NC_000019.10:48966675:GGCCCGGAGGCTGGGC:GGCCCGGAGGCTGGGCGGCCCGGAGGCTGGGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="48966675" stop="48966676" display_start="48966675" display_stop="48966676" variantLength="16" positionVCF="48966675" referenceAlleleVCF="T" alternateAlleleVCF="TGGCCCGGAGGCTGGGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="49469932" stop="49469933" display_start="49469932" display_stop="49469933" variantLength="16" positionVCF="49469932" referenceAlleleVCF="T" alternateAlleleVCF="TGGCCCGGAGGCTGGGC" />
      </Location>
      <ProteinChange>L162fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.48966676_48966691dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.48966676_48966691dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.49469933_49469948dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.49469933_49469948dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008152.1" sequenceAccession="NG_008152" sequenceVersion="1" change="g.6368_6383dup">
            <Expression>NG_008152.1:g.6368_6383dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012923.1" sequenceAccession="NG_012923" sequenceVersion="1" change="g.31663_31678dup">
            <Expression>NG_012923.1:g.31663_31678dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000146.4" sequenceAccession="NM_000146" sequenceVersion="4" change="c.469_484dup" MANESelect="true">
            <Expression>NM_000146.4:c.469_484dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000137.2" sequenceAccession="NP_000137" sequenceVersion="2" change="p.Leu162fs">
            <Expression>NP_000137.2:p.Leu162fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA281023" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="134790.0015" DB="OMIM" />
        <XRef Type="rs" ID="398124640" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000146.4(FTL):c.469_484dup (p.Leu162fs) AND Neuroferritinopathy" Accession="RCV000017952" Version="27">
        <ClassifiedConditionList TraitSetID="5415">
          <ClassifiedCondition DB="MedGen" ID="C1853578">Neuroferritinopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-04-15" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2008-04-15" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-07-22" MostRecentSubmission="2022-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301320</ID>
          <ID Source="BookShelf">NBK1141</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18413574</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5415" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3088" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neurodegeneration with brain iron accumulation 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BASAL GANGLIA DISEASE, ADULT-ONSET</ElementValue>
                <XRef Type="MIM" ID="606159" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neuroferritinopathy</ElementValue>
                <XRef ID="156901" DB="GeneTests" />
                <XRef ID="Neuroferritinopathy/5169" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011638" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA3</ElementValue>
                <XRef Type="MIM" ID="606159" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10686" />
                <XRef ID="10686" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Neuroferritinopathy is an adult-onset progressive movement disorder characterized by chorea or dystonia and speech and swallowing deficits. The movement disorder typically affects one or two limbs and progresses to become more generalized within 20 years of disease onset. When present, asymmetry in the movement abnormalities remains throughout the course of the disorder. Most individuals develop a characteristic orofacial action-specific dystonia related to speech that leads to dysarthrophonia. Frontalis overactivity and orolingual dyskinesia are common. Cognitive deficits and behavioral issues become major problems with time.</Attribute>
                <XRef ID="NBK1141" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301320</ID>
                <ID Source="BookShelf">NBK1141</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <XRef ID="157846" DB="Orphanet" />
              <XRef ID="C1853578" DB="MedGen" />
              <XRef ID="MONDO:0011638" DB="MONDO" />
              <XRef Type="MIM" ID="606159" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38231" SubmissionDate="2017-07-19" DateLastUpdated="2017-07-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="134790.0015_NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3" title="FTL, 16-BP DUP, NT469_NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3" />
        <ClinVarAccession Accession="SCV000038231" DateUpdated="2017-07-22" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-04-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Japanese mother and son with neuroferritinopathy (NBIA3; 606159), Ohta et al. (2008) identified a heterozygous 16-bp duplication (469_484dup) in exon 4 of the FTL gene, resulting in the replacement of the 14 C-terminal residues with a novel 23-amino acid sequence. The son developed hand tremors in his mid-teens and foot dragging at age 35. By age 42, he had generalized hypotonia, hyperextensibility, unsteady gait, aphonia, micrographia, hyperreflexia, and cognitive impairment. Rigidity, spasticity, dystonia, an chorea were not observed. His mother had hand tremors at age 10 and difficulty walking at age 35, developed cognitive impairment and akinetic mutism, and died at age 64. Brain imaging in both patients showed symmetric cystic changes in the basal ganglia. The son had hyperintense lesions in the basal ganglia and substantia nigra on MRI. Ohta et al. (2008) suggested that the mutant FTL protein was unable to retain iron, which was released in the nervous system, causing oxidative damage.</Attribute>
              <Citation>
                <ID Source="PubMed">18413574</ID>
              </Citation>
              <XRef DB="OMIM" ID="606159" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTL" />
          </GeneList>
          <Name>FTL, 16-BP DUP, NT469</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">16-BP DUP, NT469</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="134790.0015" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4996368" SubmissionDate="2022-07-27" DateLastUpdated="2022-10-01" DateCreated="2022-07-28">
        <ClinVarSubmissionID localKey="NM_000146.3:c.469_484dup16|OMIM:606159" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV002553192" DateUpdated="2022-10-01" DateCreated="2022-07-28" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1141</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000146.3:c.469_484dup16</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1853578" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>SUB11864799</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="38231" TraitType="Disease" MappingType="Name" MappingValue="NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3" MappingRef="Preferred">
        <MedGen CUI="C1853578" Name="Neuroferritinopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4996368" TraitType="Disease" MappingType="XRef" MappingValue="C1853578" MappingRef="MedGen">
        <MedGen CUI="C1853578" Name="Neuroferritinopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

